BlackRock Municipal Credit Alpha Portfolio files annual report
BlackRock Municipal Credit Alpha Portfolio, Inc. files annual report showing significant redemptions and no new sales, reflecting cautious market conditions.
LECAP Asset Management reveals $209M in investments
LECAP Asset Management Ltd discloses over $209 million in investments as of September 30, 2026, reflecting its strategic positioning in the asset management sector.
DT Investment Partners reports $1.37B in assets in 13F-HR
DT Investment Partners, LLC files its 13F-HR, revealing $1.37 billion in assets under management as of September 30, 2026, with key holdings in technology and healthcare.
MSG Knickerbockers Corp. Announces Virtual Annual Meeting
MSG Knickerbockers Corp. will hold its annual meeting on December 8, 2026, allowing stockholders to vote and participate virtually.
RoyaLand reveals new mobile card game, Regalia Cards
RoyaLand Co Ltd. announces the launch of Regalia Cards, a mobile card game, targeting Q4 2026 release, aiming to expand its gaming portfolio.
Wang Chun Kai Acquires Shares in Obook Holdings Inc.
CEO Wang Chun Kai of Obook Holdings Inc. purchases 11,105 shares, signaling confidence in the company's future amid the software services industry.
Radiopharm Theranostics schedules virtual Annual General Meeting
Radiopharm Theranostics Ltd announces its virtual Annual General Meeting set for November 25, 2026, adapting to digital engagement trends.
Entera Bio appoints Dr. Juan Camilo Arjona Ferreira to Board
Entera Bio Ltd. strengthens its Board with Dr. Juan Camilo Arjona Ferreira, enhancing leadership in biological products for women's health.
Jinxin Technology announces board changes with new director
Jinxin Technology Holding Co announces changes to its board, with Mr. Yu Yang appointed as an independent director following Mr. Liwei Zhang's resignation.
BlackRock Funds V Reports $2 Billion in Securities Redeemed
BlackRock Funds V's latest filing reveals over $2 billion in securities redeemed, indicating challenges in asset retention within the investment sector.
BlackRock Funds IV Reports Annual Sales and Redemptions
BlackRock Funds IV details its annual sales and redemptions in a recent SEC filing, showcasing its operations in the investment sector.
Faeth Therapeutics Expands Board with New Appointment
Faeth Therapeutics appoints Adam Schayowitz to its Board of Directors, enhancing its leadership in oncology drug development.
BlackRock Funds II reports $2.77 billion in securities sold
BlackRock Funds II files 24F-2NT, reporting $2.77 billion in securities sold and nearly $2.69 billion redeemed in fiscal year.
BlackRock Funds files 24F-2NT, no new securities registered
BlackRock Funds has filed a 24F-2NT, indicating no new securities are being registered, reflecting ongoing fund management.
Ameritas Investment Company Files MA/A Amendment with SEC
Ameritas Investment Company, LLC files an MA/A amendment with the SEC, reflecting ongoing compliance efforts in the financial services sector.
Pharming Group reports strong Q3 2026 results, revenue up 21%
Pharming Group N.V. announces Q3 2026 results with a 21% revenue increase, driven by strong demand for its products, particularly Joenja.
Innate Pharma Updates PACIFIC-9 Trial Data Readout Timing
Innate Pharma has revised the timing for the PACIFIC-9 Phase 3 trial data readout to H1 2027, reflecting the event-driven nature of the study.
AstraZeneca’s Enhertu Gains EU Approval for Early Breast Cancer
AstraZeneca’s Enhertu receives EU approval for treating HER2-positive early breast cancer, marking a significant advancement in pharmaceutical therapies.
Yimutian Inc. Announces Change to ADS Ratio Effective Nov. 16
Yimutian Inc. plans to change its ADS ratio from 6,000 to 60,000 shares, effective November 16, 2026, impacting trading dynamics in the industry.
Asset Management One Co. reports $39.96B in holdings
Asset Management One Co., Ltd. reveals $39.96 billion in holdings in its latest SEC filing, offering insights into industry trends and investment strategies.